An acqueous pharmaceutical formulation comprising the...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/55 (2006.01) A61K 9/00 (2006.01) A61K 38/05 (2006.01) A61P 7/02 (2006.01) A61K 47/18 (2006.01) A61K 47/20 (2006.01)

Patent

CA 2504480

An aqueous pharmaceutical formulation comprising the thrombin inhibitor HOOC- CH2-(R)-Cgl-Aze-Pab (melagatran), or a pharmaceutically-acceptable derivative thereof, a process for the preparation of such a pharmaceutical formulation, the use of such a formulation in the treatment of thromboembolism as well as a method of treating a patient in need of antithrombotic treatment and thromboembolism by using said formulation via nasal administration.

L'invention concerne une préparation pharmaceutique aqueuse contenant l'inhibiteur de la thrombine HOOC-CH¿2?-(R)-Cgl-Aze-Pab (melagatran), ou un dérivé pharmaceutiquement acceptable de celui-ci, un procédé permettant de préparer une telle formulation pharmaceutique, l'utilisation d'une telle formulation pour le traitement des thrombo-embolies, ainsi qu'une méthode permettant de traiter un patient nécessitant un traitement antithrombotique, et les thrombo-embolies au moyen desdites formulations administrées par voie nasale. ? ¿

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

An acqueous pharmaceutical formulation comprising the... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with An acqueous pharmaceutical formulation comprising the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and An acqueous pharmaceutical formulation comprising the... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1595869

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.